These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21640402)

  • 1. Transcatheter intervention following bosentan-iloprost treatment in a patient with patent ductus arteriosus and pulmonary hypertension.
    Guzeltas A; Odemis E; Bilici M; Tanidir IC; Özyılmaz İ
    Int J Cardiol; 2012 Jan; 154(2):e40-1. PubMed ID: 21640402
    [No Abstract]   [Full Text] [Related]  

  • 2. Bosentan treatment in an adult with pulmonary hypertension due to patent ductus arteriosus permits surgical repair.
    Mitropoulos FA; Apostolopoulou SC; Kanakis MA; Rammos S; Anagnostopoulos CE
    J Heart Lung Transplant; 2007 Dec; 26(12):1345-6. PubMed ID: 18096490
    [No Abstract]   [Full Text] [Related]  

  • 3. Bosentan in pulmonary hypertension secondary to unilateral absence of a pulmonary artery.
    Ling Y; Mei F; Wang Y; Feng Y
    Int J Cardiol; 2015 Jul; 191():34-5. PubMed ID: 25965593
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined endothelin receptor antagonist and transcatheter interventional therapy of patent ductus arteriosus with severe pulmonary artery hypertension.
    Ussia GP; Mulè M; Caruso E; Aiello R; Tamburino C
    Int J Cardiol; 2007 Apr; 116(3):427-9. PubMed ID: 16875749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New combined treatments avoided transplantation in a child with severe pulmonary hypertension.
    Beghetti M; Nicod L; Barazzone-Argiroffo C; Rimensberger PC
    Heart; 2004 Feb; 90(2):154. PubMed ID: 14729784
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemodynamic observations in two pulmonary hypertensive patients changing treatment from inhaled iloprost to the oral endothelin-antagonist bosentan.
    Fruhwald FM; Kjellström B; Perthold W; Wonisch M; Maier R; Klein W
    J Heart Lung Transplant; 2005 May; 24(5):631-4. PubMed ID: 15896766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bosentan treatment for pulmonary arterial hypertension due to patent ductus arteriosus and Down's syndrome in an infant.
    He J; Ren Y; Chen Y; Feng Y
    Int J Cardiol; 2014 Oct; 176(3):e117-8. PubMed ID: 25129297
    [No Abstract]   [Full Text] [Related]  

  • 8. Very Large Patent Ductus Arteriosus With Severe Pulmonary Arterial Hypertension.
    Konagai N; Fukui S; Kitano M; Fujimoto K; Nishii T; Ogo T; Yasuda S
    Circ J; 2019 Oct; 83(11):2325. PubMed ID: 31130586
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful switch from long-term intravenous iloprost to non-invasive combination therapy in idiopathic pulmonary arterial hypertension.
    Halank M; Kolditz M; Opitz C; Hoeffken G; Ewert R
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):54-9. PubMed ID: 16489527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful two-stage correction of ventricular septal defect and patent ductus arteriosus in a patient with fixed pulmonary hypertension.
    Pac A; Polat TB; Vural K; Pac M
    Pediatr Cardiol; 2010 Jan; 31(1):111-3. PubMed ID: 19812882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prostacyclin and iloprost in aerosol form in severe pulmonary hypertension].
    Olschewski H; Walmrath D; Schermuly R; Ghofrani HA; Grimminger F; Seeger W
    Pneumologie; 1998 Jan; 52(1):3-7. PubMed ID: 9540363
    [No Abstract]   [Full Text] [Related]  

  • 12. Experience with inhaled iloprost and bosentan in portopulmonary hypertension.
    Hoeper MM; Seyfarth HJ; Hoeffken G; Wirtz H; Spiekerkoetter E; Pletz MW; Welte T; Halank M
    Eur Respir J; 2007 Dec; 30(6):1096-102. PubMed ID: 17652314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy for portopulmonary hypertension with intravenous iloprost and oral bosentan.
    Halank M; Kolditz M; Miehlke S; Schiemanck S; Schmeisser A; Hoeffken G
    Wien Med Wochenschr; 2005 Aug; 155(15-16):376-80. PubMed ID: 16160926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension.
    Hoeper MM; Leuchte H; Halank M; Wilkens H; Meyer FJ; Seyfarth HJ; Wensel R; Ripken F; Bremer H; Kluge S; Hoeffken G; Behr J
    Eur Respir J; 2006 Oct; 28(4):691-4. PubMed ID: 17012628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter intervention following ambrisentan treatment in an adult patient with patent ductus arteriosus and severe pulmonary hypertension.
    Yunfei L; Ke L; Qi A; Yuan F
    Int J Cardiol; 2014 May; 173(2):e16-7. PubMed ID: 24680251
    [No Abstract]   [Full Text] [Related]  

  • 16. [Transcatheter closure of wide, patent ductus arteriosus in an adult patient with severe pulmonary hypertension-a case report].
    Kepka C; Demkow M; Dzielińska Z; Ruzyłło W
    Kardiol Pol; 2003 Dec; 59(12):517-8. PubMed ID: 14724700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of pulmonary hypertension in the immediate period after general anesthesia and surgical correction of patent ductus arteriosus and heart septal defects].
    Gimmel'farb GN; Karimova TZ
    Vestn Khir Im I I Grek; 1988 Jun; 140(6):123-6. PubMed ID: 3222850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
    Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM
    J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Closure of wide patent ductus arteriosus using a fenestrated muscular VSD occluder device in a pediatric patient with Down syndrome and pulmonary hypertension].
    Güvenç O; Saygı M; Demir İH; Ödemiş E
    Turk Kardiyol Dern Ars; 2017 Jun; 45(4):373-376. PubMed ID: 28595211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of severe pulmonary hypertension with inhaled iloprost.
    Leuchte HH; Baumgartner RA; Behr J
    Ann Intern Med; 2003 Aug; 139(4):306. PubMed ID: 12965995
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.